Literature DB >> 1996787

Endotoxin-induced endothelial injury and subendothelial accumulation of fibronectin in rat aorta.

Y H Kang1, R Williams.   

Abstract

Endotoxin (lipopolysaccharide, LPS) induces endothelial injury in arterial vessels. Fibronectin is known to be involved in cell attachment and wound repair. The present study was designed to elucidate the effect of LPS on the production and distribution of fibronectin in relation to injury and repair in rat aortic endothelium. Male Sprague-Dawley rats were sacrificed for ultrastructural and immunocytochemical evaluations at 1, 3, 6, 24, and 48 hr after a single intravenous injection of 1.5 or 3 mg/kg body weight E. coli LPS. Apparent morphological signs of endothelial injury, including cell detachment, denudation, cell death, and edema were observed 1-48 hr after injection. Parietal thrombosis and leukocyte diapedesis were also observed in the aorta. A profound increase in subendothelial fibronectin was found following LPS treatment. However, no distinct change in intracellular fibronectin was observed in the same endothelium until 24 hr after injection. Using horseradish peroxidase (HRP) and anti-fibronectin-HRP antibody as tracers, LPS was also found to increase permeability and extravasation of plasma proteins (fibronectin) of the aortic endothelium. The increase of subendothelial fibronectin possibly resulted from increased influx and sequestration of plasma fibronectin. This increase may provide a firm substratum for reendothelialization after vascular injury.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1996787     DOI: 10.1002/ar.1092290110

Source DB:  PubMed          Journal:  Anat Rec        ISSN: 0003-276X


  8 in total

1.  Induction mechanism of small intestinal lesions caused by intravenous injection of endotoxin in rats.

Authors:  M Shindo; M Majima; T Ohno; K Sugimoto; T Ohwada
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

2.  Pretreatment with peroxysome proliferator-activated receptor alpha agonist fenofibrate protects endothelium in rabbit Escherichia coli endotoxin-induced shock.

Authors:  Eric Wiel; Gilles Lebuffe; Emmanuel Robin; Gaëlle Gasan; Delphine Corseaux; Benoît Tavernier; Brigitte Jude; Régis Bordet; Benoît Vallet
Journal:  Intensive Care Med       Date:  2005-08-16       Impact factor: 17.440

3.  Phenotypic modulation of smooth muscle cells during the formation of neointimal thickenings in the rat carotid artery after balloon injury: an electron-microscopic and stereological study.

Authors:  J Thyberg; K Blomgren; U Hedin; M Dryjski
Journal:  Cell Tissue Res       Date:  1995-09       Impact factor: 5.249

4.  Enteric vascular endothelial response to bacterial endotoxin.

Authors:  R Koshi; V I Mathan; S David; M M Mathan
Journal:  Int J Exp Pathol       Date:  1993-12       Impact factor: 1.925

5.  Fn-EDA (Fibronectin Containing Extra Domain A) in the Plasma, but Not Endothelial Cells, Exacerbates Stroke Outcome by Promoting Thrombo-Inflammation.

Authors:  Nirav Dhanesha; Mehul R Chorawala; Manish Jain; Abhinav Bhalla; Daniel Thedens; Manasa Nayak; Prakash Doddapattar; Anil K Chauhan
Journal:  Stroke       Date:  2019-05       Impact factor: 7.914

6.  Microvascular effects of oral interleukin-6 on ischemia/reperfusion in the murine small intestine.

Authors:  F M Rollwagen; Y Y Li; N D Pacheco; E J Dick; Y H Kang
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

7.  IL-1α-induced microvascular endothelial cells promote neutrophil killing by increasing MMP-9 concentration and lysozyme activity.

Authors:  Xiaoye Liu; Hong Dong; Mingming Wang; Ying Gao; Tao Zhang; Ge Hu; Huiqing Duan; Xiang Mu
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

8.  Activated protein C increases sensitivity to vasoconstriction in rabbit Escherichia coli endotoxin-induced shock.

Authors:  Eric Wiel; Marion Elizabeth Costecalde; Gilles Lebuffe; Delphine Corseaux; Brigitte Jude; Régis Bordet; Benoît Tavernier; Benoît Vallet
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.